Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Dr. Scott Gottlieb on promising new cancer drug data: 'The future is here'
10:56am, Monday, 06'th Jun 2022
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss the top drug trial data coming out of the American Society of Clinical Oncology conference in Ch
7 Cheap Growth Stocks That Won't Stay That Way for Long
07:00am, Monday, 06'th Jun 2022
Investors foolishly sent these stocks into cheap territory, ignoring the near-term growth prospects that will reward them soon. The post 7 Cheap Growth Stocks That Won't Stay That Way for Long appeare
100 Billion Reasons to Like This Dominant Healthcare Stock
07:00am, Monday, 06'th Jun 2022
This mega-cap stock will become the first in the pharmaceutical industry to reach a major sales milestone.
Is There More Room For Growth In Bristol Myers Squibb Stock?
06:00am, Monday, 06'th Jun 2022
Bristol Myers Squibb stock (NYSE: BMY), which currently trades at $75 per share, looks like it has only a little room for growth.
Can the Best-Selling Drugs of 2021 Repeat Their Performance?
05:43am, Sunday, 05'th Jun 2022
These were the industry's bestsellers last year, but how long can they stay on top?
BMY, IMTX Extend Deal to Develop Cell Therapies for Cancer
05:18pm, Friday, 03'rd Jun 2022
Bristol Myers (BMY) strengthens its partnership with the small biotech company Immatics (IMTX) to develop multiple allogenic cell therapies targeting multiple cancer indications.
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
05:11pm, Friday, 03'rd Jun 2022
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way. The post 6 Biotech Stocks to Buy Now Ahead o
Turning Point Therapeutics' Shares Soar on Bristol-Myers Squibb Deal
02:49pm, Friday, 03'rd Jun 2022
Turning Point Therapeutics Inc. ( TPTX , Financial) shareholders got a good start to the weekend as the stock soared on news that Bristol-Myers Squibb Co. ( BMY , Financial) is buying the San Diego-ba
Here is Why Turning Point Therapeutics Jumped 110%
12:08pm, Friday, 03'rd Jun 2022
Turning Point Therapeutics Inc (NASDAQ: TPTX) jumped 110% after announcing a definitive merger agreement with Bristol Myers Squibb Co (NYSE: BMY). Under the agreement, Bristol Myers Squibb will acquir
Turning Point Therapeutics shares more than doubled on Friday
12:08pm, Friday, 03'rd Jun 2022
Shares of Turning Point Therapeutics Inc (NASDAQ: TPTX) more than doubled on Friday after Bristol-Myers Squibb Co (NYSE: BMY) said it will buy the biotech company for $4.10 billion in cash. Bristol-My
Best Health Care Stocks To Invest In Today? 3 In Focus
12:02pm, Friday, 03'rd Jun 2022
Could these health care stocks be worth jumping on now?
TPTX Stock Soars 115% as Bristol Myers Announces Takeover of Turning Point Therapeutics
10:43am, Friday, 03'rd Jun 2022
Turning Point Therapeutics (TPTX) stock is rocketing higher on Friday following news of a deal with Bristol-Myers Squibb (BMY). The post TPTX Stock Soars 115% as Bristol Myers Announces Takeover of T
Is This Dividend Stock a Buy for Income Investors?
10:15am, Friday, 03'rd Jun 2022
There has been a significant rotation from growth stocks into value stocks this year.
Turning Point Stock Doubles After Bristol Myers Announces Takeover
07:32am, Friday, 03'rd Jun 2022
The pharma giant said it would pay $76 a share for the biotech stock, up from Thursday's close of $34.16.
Why Bristol-Myers Squibb (BMY) Is Buying Turning Point Therapeutics (TPTX) In A $4.1 Billion Deal
07:19am, Friday, 03'rd Jun 2022
Bristol Myers Squibb (NYSE: BMY) is buying Turning Point Therapeutics, Inc. (NASDAQ: TPTX) in a $4.1 billion deal. These are the details.
